320 related articles for article (PubMed ID: 11458069)
1. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
[TBL] [Abstract][Full Text] [Related]
2. Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.
Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
Scand J Urol Nephrol; 2007; 41(1):32-41. PubMed ID: 17366100
[TBL] [Abstract][Full Text] [Related]
3. Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 years.
Robert G; Descazeaud A; Azzouzi R; Saussine C; Haillot O; Dumonceau O; Ballereau C; Fourmarier M; Devonec M; Lukacs B; Delongchamps NB; Desgrandchamps F; de la Taille A
Urol Int; 2010; 84(4):424-9. PubMed ID: 20339294
[TBL] [Abstract][Full Text] [Related]
4. Relationship between lower urinary tract symptoms frequency assessed by the IPSS and bothersomeness (SPI) among men older than 50 years old.
Perrin P; Marionneau N; Cucherat M; Taieb C
Eur Urol; 2005 Oct; 48(4):601-7. PubMed ID: 16055260
[TBL] [Abstract][Full Text] [Related]
5. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
6. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
7. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
8. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia.
Homma Y; Yamaguchi T; Kondo Y; Horie S; Takahashi S; Kitamura T
J Urol; 2002 Jan; 167(1):172-6. PubMed ID: 11743299
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
10. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC; Elhilali M; Vallancien G;
BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
[TBL] [Abstract][Full Text] [Related]
12. A community based study of prostatic symptoms in Singapore.
Tan HY; Choo WC; Archibald C; Esuvaranathan K
J Urol; 1997 Mar; 157(3):890-3. PubMed ID: 9072593
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
14. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.
Coyne KS; Wein AJ; Tubaro A; Sexton CC; Thompson CL; Kopp ZS; Aiyer LP
BJU Int; 2009 Apr; 103 Suppl 3():4-11. PubMed ID: 19302497
[TBL] [Abstract][Full Text] [Related]
15. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
16. Changes in prevalence of urinary symptoms in Finnish men--a population-based 5-year follow-up study.
Häkkinen J; Koskimäki J; Huhtala H; Tammela TL; Hakama M; Auvinen A
Scand J Urol Nephrol; 2004; 38(5):378-84. PubMed ID: 15764248
[TBL] [Abstract][Full Text] [Related]
17. Seasonal changes in symptom score and uroflowmetry in patients with lower urinary tract symptoms.
Watanabe T; Maruyama S; Maruyama Y; Kageyama S; Shinbo H; Otsuka A; Ozono S
Scand J Urol Nephrol; 2007; 41(6):521-6. PubMed ID: 17853015
[TBL] [Abstract][Full Text] [Related]
18. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
O'Leary MP; Wei JT; Roehrborn CG; Miner M;
BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
[TBL] [Abstract][Full Text] [Related]
19. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.
Ushijima S; Ukimura O; Okihara K; Mizutani Y; Kawauchi A; Miki T
J Urol; 2006 Aug; 176(2):665-71. PubMed ID: 16813918
[TBL] [Abstract][Full Text] [Related]
20. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association.
Barry MJ; Fowler FJ; O'Leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK
Med Care; 1995 Apr; 33(4 Suppl):AS145-55. PubMed ID: 7536866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
